PRO-DEX Reports Strong Q2 Earnings, Significant Cash Inflow from Monogram Sale, and Key Customer Contract Extension

summarizeSummary

PRO-DEX reported strong Q2 financial results, including a 17.4% increase in year-to-date net sales and a 52.4% rise in net income, driven by an $8.9 million cash infusion from the Monogram Technologies acquisition and a key customer contract extension.

check_boxKey Events

• Strong Q2 and Year-to-Date Financial Performance

  Net sales for the six months ended December 31, 2025, increased by 17.4% to $37.194 million, while net income surged by 52.4% to $6.867 million compared to the prior year period. Basic EPS for the six months increased to $2.11 from $1.36.

• Significant Cash Inflow from Monogram Technologies Acquisition

  The company received $8.9 million in cash proceeds from Zimmer Biomet Holdings, Inc.'s acquisition of Monogram Technologies, Inc. on October 7, 2025, realizing a gain of $6.8 million. PRO-DEX also received non-tradeable contingent value rights (CVRs) with a potential total value of up to $12.37 million if milestones are achieved.

• Operating Cash Flow Turnaround and Enhanced Liquidity

  Net cash provided by operating activities for the six months ended December 31, 2025, was $5.882 million, a significant improvement from net cash used of $2.263 million in the prior year. Cash and cash equivalents increased to $7.953 million from $419,000 at June 30, 2025, and working capital increased by $9.824 million to $36.985 million.

• Major Customer Contract Extended Through 2028

  PRO-DEX's largest customer executed an amendment to an existing supply agreement, extending the supply of surgical handpieces through calendar year 2028, providing significant revenue visibility and stability.

auto_awesomeAnalysis

PRO-DEX, INC. delivered robust financial results for the second quarter and first half of fiscal 2026, marked by substantial growth in net sales and net income, and a significant turnaround in operating cash flow. The company received $8.9 million in cash from the acquisition of its Monogram Technologies investment, which, along with potential future contingent value rights, provides a strong liquidity boost. The extension of a major customer contract through 2028 enhances revenue stability and visibility. While the CEO has adopted a pre-planned 10b5-1 trading arrangement to sell a notable amount of shares, the overall financial health and strategic progress outlined in this report are highly positive for the company's outlook.